Investing.com - BeiGene reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
BeiGene announced earnings per share of $0.69 on revenue of $605.87M. Analysts polled by Investing.com anticipated EPS of $-1.9 on revenue of $256.28M.
BeiGene shares are up 4.26% from the beginning of the year and are trading at $314.00 , down-from-52-week-high.They are under-performing the Nasdaq which is up 5.78% from the start of the year.
BeiGene follows other major Healthcare sector earnings this month
BeiGene's report follows an earnings beat by J&J on Tuesday, April 20, 2021, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Pfizer had beat expectations on Tuesday with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7773 on revenue of $13.67B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar